Daiwa Securities Group Inc. increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 317.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,949,368 shares of the real estate investment trust's stock after buying an additional 3,003,845 shares during the period. Daiwa Securities Group Inc. owned 1.46% of Omega Healthcare Investors worth $160,739,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Versant Capital Management Inc purchased a new position in Omega Healthcare Investors during the second quarter valued at $26,000. UMB Bank n.a. increased its stake in shares of Omega Healthcare Investors by 353.4% in the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 516 shares in the last quarter. DiNuzzo Private Wealth Inc. purchased a new position in Omega Healthcare Investors during the 3rd quarter valued at about $33,000. V Square Quantitative Management LLC lifted its position in Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust's stock valued at $40,000 after acquiring an additional 323 shares during the period. Finally, Capital Performance Advisors LLP bought a new stake in Omega Healthcare Investors during the third quarter worth about $48,000. 65.25% of the stock is owned by institutional investors.
Omega Healthcare Investors Stock Down 0.1 %
Shares of OHI traded down $0.03 during midday trading on Friday, reaching $40.11. 1,745,104 shares of the stock were exchanged, compared to its average volume of 2,025,181. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $10.83 billion, a P/E ratio of 29.49, a PEG ratio of 1.25 and a beta of 0.99. The company's 50 day moving average is $40.62 and its two-hundred day moving average is $37.01. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42.
Omega Healthcare Investors Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.68%. Omega Healthcare Investors's dividend payout ratio is currently 197.06%.
Analyst Ratings Changes
Several research analysts have recently issued reports on OHI shares. Scotiabank upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research note on Monday, August 26th. BNP Paribas upgraded shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 target price for the company in a research report on Thursday, October 31st. Truist Financial increased their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, September 4th. Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They set a "buy" rating and a $45.00 price target on the stock. Finally, Royal Bank of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a research report on Monday, November 11th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Omega Healthcare Investors currently has an average rating of "Hold" and an average target price of $40.00.
Check Out Our Latest Research Report on OHI
Insider Buying and Selling
In other news, CFO Robert O. Stephenson sold 22,542 shares of the firm's stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.
Omega Healthcare Investors Company Profile
(
Free Report)
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
See Also
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.